| Issue |
Section |
Title |
File |
| Vol 30, No 4 (2019) |
Articles |
Psychoautonomic status and silent myocardial ischemia in premenopause in the presence of metabolically healthy obesity |
|
| Vol 30, No 8 (2019) |
Articles |
Silent myocardial ischemia and hormonal contraception in young women with metabolic syndrome |
|
| Vol 32, No 1 (2021) |
Articles |
Quality of life in young women with hypertension and an altered hormonal background |
|
| Vol 32, No 3 (2021) |
Articles |
Silent myocardial ischemia in young women with cardialgia, dyshormonosis, and various comorbidities (cardiac and extracardiac ones) |
|
| Vol 32, No 4 (2021) |
Articles |
THE EFFECT OF GLYCINE AND LISINOPRIL ON QUALITY OF LIFE IN WOMEN WITH HYPERTENSION AND ESTROGEN DEFICIENCY |
|
| Vol 32, No 11 (2021) |
Articles |
The effects of glycine and lisinopril on anxiety, the social functioning of young males with hypertension and androgen deficiency |
|
| Vol 33, No 2 (2022) |
Articles |
Arterial hypertension in perimenopause: effects of lisinopril and Femo-Clim combination on the hypotensive effect, functional state of endothelium, cardiac remodeling and quality of life |
|
| Vol 33, No 3 (2022) |
Articles |
THE EFFECT OF THE DRUG FEMO-KLIM ON THE QUALITY OF LIFE OF YOUNG WOMEN WITH ALTERED HORMONAL BACKGROUND |
|
| Vol 33, No 4 (2022) |
Articles |
Effect of Femo-Klim on psycho-autonomic status, episodes of cardialgia in premenopausal women with metabolically healthy obesity and estrogen deficiency |
|
| Vol 33, No 5 (2022) |
Pharmacology |
The efficacy of Nervo-Vit in premenopausal patients: its effect on social activity, anxiety, and quality of life |
|
| Vol 33, No 6 (2022) |
Pharmacology |
The impact of combination therapy with Femoklim and Nervo-Vit on the psychological state of women with estrogen deficiency and metabolically healthy obesity |
|
| Vol 33, No 9 (2022) |
Pharmacology |
The impact of Equapress therapy on cardiac remodeling and myocardial ischemia in premenopausal patients with hypoestrogenemia |
|
| Vol 33, No 10 (2022) |
Articles |
THE IMPACT OF COMBINATION THERAPY WITH FEMOKLIM AND NERVO-VIT ON THE INDICATORS OF ANXIETY AND SOCIAL ACTIVITY IN PREMENOPAUSAL PATIENTS WITH ESTROGEN DEFICIENCY |
|
| Vol 30, No 3 (2019) |
Articles |
Therapy for cardiac remodeling in young men with hypertension, androgen deficiency, and dyslipidemia |
|
| Vol 24, No 9 (2013) |
Articles |
IMPACT OF LONG-TERM CO-DIROTON THERAPY ON HEART REMODELLING, SILENT MYOCARDIAL ISCHEMIA IN HYPRTENSIVE DISEASE WITH ESTROGEN DEFICINCY IN PREMENOPAUSE |
|
| Vol 26, No 12 (2015) |
Articles |
LEFT CARDIAC REMODELING IN MALE HYPERTENSIVE PATIENTS HAVING A NORMAL OR ALTERED HORMONAL PROFILE |
|
| Vol 26, No 9 (2015) |
Articles |
INTERGENIC INTERACTIONS IN THE DEVELOPMENT OF SILENT MYOCARDIAL ISCHEMIA |
|
| Vol 27, No 4 (2016) |
Articles |
THERAPY IN WOMEN WITH HYPERTENSION AND ESTROGEN DEFICIENCY IN THE LATE FERTILE PERIOD |
|
| Vol 28, No 3 (2017) |
Articles |
CEREBRAL HEMODYNAMICS IN YOUNG WOMEN WITH HYPERTENSION AND ESTROGEN DEFICIENCY |
|
| Vol 28, No 1 (2017) |
Articles |
ACTION ON CARDIAC REMODELING IN HYPERTENSION WITH HYPOESTROGENEMIA AND DYSLIPIDEMIA |
|
| Vol 29, No 1 (2018) |
Articles |
Hemodynamic parameters in women with hypoestrogenemia with metabolically healthy obesity |
|
| Vol 28, No 9 (2017) |
Articles |
DYSRHYTHMIAS IN HYPOESTROGENEMIA WITH METABOLICALLY HEALTHY OBESITY |
|
| Vol 29, No 4 (2018) |
Articles |
Cerebral hemodynamics in hypertension and androgen deficiency |
|
| Vol 29, No 2 (2018) |
Articles |
The vascular bed in estrogen deficiency with hypertension and obesity |
|
| Vol 29, No 7 (2018) |
Articles |
Hormone replacement and cardiotropic therapy in young men with hypertension, overweight, and androgen deficiency |
|
| Vol 29, No 10 (2018) |
Articles |
Impact of triple antihypertensive therapy on cardiac remodeling, silent myocardial ischemia in hypertension in premenopausal women with estrogen deficiency |
|
| Vol 33, No 11 (2022) |
From Practice |
Cardiometabolic and anti-ischemic therapy for cardiovascular disease and estrogen deficiency |
|
| Vol 34, No 3 (2023) |
Pharmacology |
Impact of metabolic therapy on the state of cerebral hemodynamics in hypoestrogenemia |
|
| Vol 34, No 2 (2023) |
From Practice |
Evaluation of the effect of metabolic therapy on the state of blood vessels in estrogen deficiency and hypertension |
|
| Vol 34, No 4 (2023) |
From Practice |
Effect of Femoklim on the state of blood vessels in hypoestrogenemia and arterial hypertension |
|
| Vol 34, No 5 (2023) |
Pharmacology |
Effect of metabolic therapy on the state of the vascular bed in premenopausal dyslipidemia |
|
| Vol 34, No 6 (2023) |
Pharmacology |
Effect of Equamer on cardialgia and psychoautonomic status in woman with metabolically healthy obesity, estrogen deficiency, and hypertension in the late fertile period |
|
| Vol 34, No 7 (2023) |
From Practice |
Osteointegration of dental implants in menopausal osteoporosis: optimization strategies, ways and prospects of solving the problem |
|
| Vol 34, No 8 (2023) |
From Practice |
Hypertension therapy with Equator according to the genotype of the estrogen receptor gene |
|
| Vol 34, No 9 (2023) |
From Practice |
Psychocorrective and cardiotropic therapy in young men with hypertension, overweight and androgen deficiency |
|
| Vol 34, No 11 (2023) |
From Practice |
Therapy of dysrhythmias in young women with estrogen deficiency, arterial hypertension, and "metabolically healthy" abdominal obesity |
|
| Vol 34, No 12 (2023) |
Pharmacology |
Effect of selenium-containing vitamin and mineral complex on women's health |
|
| Vol 35, No 1 (2024) |
From Practice |
Relationship between selenium and hematologic markers in overweight and anemic patients |
|
| Vol 35, No 4 (2024) |
From Practice |
Psycho-correction therapy of patients with «metabolically healthy» obesity |
|
| Vol 35, No 4 (2024) |
From Practice |
Anti-ischemic and cardiometabolic therapy in cardiovascular pathology |
|
| Vol 35, No 2 (2024) |
From Practice |
Review of current research on microvascular angina |
|
| Vol 35, No 5 (2024) |
From Practice |
Modern therapy for cardiac arrhythmias in patients with hypertension and obesity |
|
